Fludarabine Induces Differential Expression of Proteins in Human Leukemia and Lymphoma Cells

REFERENCES

• Lamanna , N. and Weiss , M. 2004 . Purine analogs in leukemia . Adv. Pharmacol. , 51 : 107 – 125 .
   PubMedGoogle Scholar
• Pettitt , A. R. 2003 . Mechanism of action of purine analogues in chronic lymphocytic leukaemia . Br. J. Haematol. , 121 : 692 – 702 .
   PubMed Web of Science ®Google Scholar
• Elter , T. , Hallek , M. and Engert , A. 2006 . Fludarabine in chronic lymphocytic leukaemia . Expert Opin. Pharmacother. , 7 : 1641 – 1651 .
   PubMed Web of Science ®Google Scholar
• Pettitt , A. R. , Clarke , A. R. , Cawley , J. C. and Griffiths , S. D. 1999 . Purine analogues kill resting lymphocytes by p53-dependent and -independent mechanisms . Br. J. Haematol. , 105 : 986 – 988 .
   PubMed Web of Science ®Google Scholar
• Henrich , S. , Cordwell , S. J. , Crossett , B. , Baker , M. S. and Christopherson , R. I. 2007 . The nuclear proteome and DNA-binding fraction of human Raji lymphoma cells . Biochim. Biophys. Acta , 1774 : 413 – 432 .
   PubMed Web of Science ®Google Scholar
• Belov , L. , Huang , P. , Barber , N. , Mulligan , S. P. and Christopherson , R. I. 2003 . Identification of repertoires of surface antigens on leukemias using an antibody microarray . Proteomics , 3 : 2147 – 2154 .
   PubMed Web of Science ®Google Scholar
• Toledo , F. and Wahl , G. M. 2006 . Regulating the p53 pathway: in vitro hypotheses, in vivo veritas . Nature , 6 : 910 – 923 .
   Web of Science ®Google Scholar
• Roos , W. P. and Kaina , B. 2006 . DNA damage-induced cell death by apoptosis . Trends Mol. Med. , 12 : 440 – 450 .
   PubMed Web of Science ®Google Scholar
• Sadji-Ouatas , Z. , Lasfer , M. , Julien , S. , Feldmann , G. and Reyl-Desmars , F. 2002 . Doxorubicin and octreotide induce a 40 kDa breakdown product of p53 in human hepatoma and tumoral colon cell lines . Biochem. J. , 364 : 881 – 885 .
   PubMed Web of Science ®Google Scholar
• Okorokov , A. L. and Milner , J. 1997 . Proteolytic cleavage of p53: a model for the activation of p53 in response to DNA damage . Oncol. Res. , 9 : 267 – 273 .
   PubMed Web of Science ®Google Scholar
• Byrd , J. C. , Rai , K. , Peterson , B. L. , Appelbaum , F. R. , Morrison , V. A. , Kolitz , J. E. , Shepherd , L. , Hines , J. D. , Schiffer , C. A. and Larson , R. A. 2005 . Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011 . Blood , 105 : 49 – 53 .
   PubMed Web of Science ®Google Scholar